Senaparib

Generic Name
Senaparib
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C24H20F2N6O3
CAS Number
1401682-78-7
Unique Ingredient Identifier
MNZ4OP95CF
Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News
nature.com
·

Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer

Article references discuss global cancer statistics, treatment strategies for ovarian cancer, and the prognostic impact of histological responses to neoadjuvant chemotherapy, including the development and validation of a chemotherapy response score system.

Related Clinical Trials:

Prevalence of BRCA in Patients With Ovarian Cancer
finance.yahoo.com
·

Pipeline Moves: Pfizer scores in Phase II cancer cachexia trial

Pfizer's ponsegromab shows positive Phase II results in cancer cachexia, Merck's Keytruda PTSR rises in thymic carcinoma, Teva's Austedo completes Phase II dystonia trial, IMPACT's senaparib sees PTSR drop in solid tumours, Acrotech's Beleodaq and Vitti's EV-PURE face Phase I suspensions.

Related Clinical Trials:

A Study of Ponsegromab in People With Heart Failure
Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents
An Open-label Study to Define the Safety, Tolerability and Clinical Activity of Deutetrabenazine (AUstedo) in Adult Study Subjects With DYsTonia
Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15
A Clinical Study of IMP4297 Capsule (JS109) Combined With Irinotecan in the Treatment of Advanced Malignant Solid Tumors
Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment
A Proof of Concept Study to Evaluate Exosomes From Human Mesenchymal Stem Cells in Women With Premature Ovarian Insufficiency (POI)
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy